In contrast, it has also been shown that RUNX1 levels are abnormally elevated in triple-negative breast cancer (TNBC) and this is associated with a poor prognosis, indicating that RUNX1 plays a pro-tumor role in TNBC [42]. Here, RUNX1 is linked to triple-negative breast carcinoma.